Do Lipid-Lowering Agents Provide a Greater Reduction in Cardiovascular Events among Patients with Diabetes?

  1. Ned Calonge, MD, MPH; and
  2. Diana Petitti, MD, MPH
  1. From the Colorado Department of Public Health and Environment, Denver, CO 80246, and Keck School of Medicine, University of Southern California, Los Angeles, CA 90089.

    IN RESPONSE:

    In making its recommendation on screening for type 2 diabetes, the USPSTF considered interventions, including lipid-lowering agents, for effects on such health outcomes as cardiovascular events. In reviewing the evidence on lipid-lowering agents, the USPSTF found that persons with diabetes do …

    « Previous | Next Article »Table of Contents